UNSPSC 51284036: Oxytetracycline anhydrous

This classification denotes a tetracycline antibiotic with the molecular formula C22H24N2O9, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier SLF0D9077S, chemically known as oxytetracycline (anhydrous) [hsdb], but more generally known as oxytetracycline anhydrous, which bears US NIH Compound Identifier 5280972. European Medicines Agency schedules oxytetracycline anhydrous or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09579MIG.

Most nations, for tariff purposes, schedule oxytetracycline anhydrous under HS 29413000. Oxytetracycline anhydrous bears US NLM identifiers UMLS ID C2698682 and NCI Concept Code C74596. SMILES: C[C@]1(C2CCCC(C2C(=O)C3=C([C@]4([C@@H]([C@H]([C@@H]31)O)[C@@H](C(=C(C4=O)C(=O)N)O)N(C)C)O)O)O)O.

UNSPSC 51284036 Oxytetracycline anhydrous is a Commodity code covering pharmaceutical active ingredients and finished-dose antibiotic products. State and local procurement activity under this code reflects sourcing of pharmaceutical stockpiles and supply-chain replenishment through consortial purchasing vehicles, particularly for emergency preparedness, public health initiatives, and community health programs. Issuing bodies soliciting under the code include state health departments and county health authorities, which typically aggregate demand through cooperative purchasing agreements to secure volume pricing and streamlined procurement workflows.

Recent opportunities show Illinois Department of Public Health and Seminole County, Florida executing pharmaceutical procurements via piggyback contracts and competitive bidding. The Illinois Department of Public Health awarded a $2,999,999.11 three-year piggyback pharmaceutical warehouse contract to Chartwell Rx LLC on August 28, 2026, through the MMCAP Infuse consortium for supply of Doxycycline Hyclate 100mg tablets and Ciprofloxacin Hydrochloride 500mg tablets—related tetracycline-class and fluoroquinolone antibiotics—with 12-month initial term and renewal options for years 2 and 3. Seminole County, Florida issued an IFB on June 30, 2026, for 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually with quarterly deliveries to the Seminole County Community Health Building, Sanford, and a July 26, 2023, response deadline. Activity appears concentrated in Florida and Illinois, with procurement routed through state cooperative vehicles such as MMCAP Infuse and direct county health procurement offices.